JPWO2021213475A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021213475A5 JPWO2021213475A5 JP2022564073A JP2022564073A JPWO2021213475A5 JP WO2021213475 A5 JPWO2021213475 A5 JP WO2021213475A5 JP 2022564073 A JP2022564073 A JP 2022564073A JP 2022564073 A JP2022564073 A JP 2022564073A JP WO2021213475 A5 JPWO2021213475 A5 JP WO2021213475A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- chain variable
- variable region
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010324783 | 2020-04-22 | ||
| CN202010324783.4 | 2020-04-22 | ||
| CN202110270671.X | 2021-03-12 | ||
| CN202110270671 | 2021-03-12 | ||
| PCT/CN2021/089059 WO2021213475A1 (zh) | 2020-04-22 | 2021-04-22 | 抗cd73-抗pd-1双特异性抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522730A JP2023522730A (ja) | 2023-05-31 |
| JPWO2021213475A5 true JPWO2021213475A5 (ko) | 2023-07-10 |
Family
ID=78094648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564073A Pending JP2023522730A (ja) | 2020-04-22 | 2021-04-22 | 抗ｃｄ７３／抗ｐｄ－１二重特異性抗体及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230151111A1 (ko) |
| EP (1) | EP4141033A4 (ko) |
| JP (1) | JP2023522730A (ko) |
| KR (1) | KR20230004726A (ko) |
| CN (1) | CN113527501A (ko) |
| AU (1) | AU2021261803A1 (ko) |
| BR (1) | BR112022021426A2 (ko) |
| CA (1) | CA3176321A1 (ko) |
| IL (1) | IL297432A (ko) |
| MX (1) | MX2022013311A (ko) |
| WO (1) | WO2021213475A1 (ko) |
| ZA (1) | ZA202211405B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021363350A1 (en) * | 2020-10-23 | 2023-06-22 | Akeso Biopharma, Inc | Anti-cd73 antibody and use thereof |
| CN118530341A (zh) * | 2021-03-12 | 2024-08-23 | 中山康方生物医药有限公司 | 提高含有免疫球蛋白Fc片段的药物的有效性的方法 |
| AU2023252914A1 (en) | 2022-04-13 | 2024-10-17 | Arcus Biosciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
| CA3208473A1 (en) * | 2022-06-22 | 2023-12-22 | Akeso Biopharma, Inc. | Pharmaceutical composition and use thereof |
| CN116813786A (zh) * | 2023-08-03 | 2023-09-29 | 贝达药业股份有限公司 | 抗cd73抗体及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| CA2802344C (en) * | 2010-06-18 | 2023-06-13 | The Brigham And Women's Hospital, Inc. | Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions |
| SG11201703332SA (en) * | 2014-11-10 | 2017-05-30 | Medimmune Ltd | Binding molecules specific for cd73 and uses thereof |
| GB2538120A (en) | 2014-11-11 | 2016-11-09 | Medimmune Ltd | Therapeutic combinations comprising anti-CD73 antibodies and uses thereof |
| ME03806B (me) * | 2014-11-21 | 2021-04-20 | Bristol Myers Squibb Co | Antitela protiv cd73 i njihova upotreba |
| US20190330335A1 (en) * | 2015-10-06 | 2019-10-31 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| IL290457B1 (en) * | 2015-12-30 | 2024-10-01 | Kodiak Sciences Inc | Antibodies and their conjugates |
| IL295230A (en) * | 2016-03-04 | 2022-10-01 | Bristol Myers Squibb Co | Combination therapy with anti-cd73 antibodies |
| MX2019001448A (es) * | 2016-08-05 | 2019-09-13 | Chugai Pharmaceutical Co Ltd | Composicion para profilaxis o tratamiento de enfermedades relacionadas con interleucina 8 (il-8). |
| CN106977602B (zh) * | 2016-08-23 | 2018-09-25 | 中山康方生物医药有限公司 | 一种抗pd1单克隆抗体、其药物组合物及其用途 |
| CN106967172B (zh) * | 2016-08-23 | 2019-01-08 | 康方药业有限公司 | 抗ctla4-抗pd-1 双功能抗体、其药物组合物及其用途 |
| KR20200096921A (ko) * | 2017-11-06 | 2020-08-14 | 코버스 파마슈티칼스, 인크. | 암 치료를 위한 아데노신 경로 억제제 |
| EP3762030A4 (en) * | 2018-03-09 | 2022-01-05 | Phanes Therapeutics, Inc. | ANTI-CD73 ANTIBODIES AND USES THEREOF |
| AU2019252795A1 (en) * | 2018-04-12 | 2020-10-29 | Bristol-Myers Squibb Company | Anticancer combination therapy with cd73 antagonist antibody and pd-1/pd-l1 axis antagonist antibody |
| WO2020020307A1 (en) * | 2018-07-25 | 2020-01-30 | I-Mab Biopharma Co., Ltd. | Anti-cd73 anti-pd-l1 bispecific antibodies |
| CN109053895B (zh) * | 2018-08-30 | 2020-06-09 | 中山康方生物医药有限公司 | 抗pd-1-抗vegfa的双功能抗体、其药物组合物及其用途 |
-
2021
- 2021-04-22 KR KR1020227040580A patent/KR20230004726A/ko active Search and Examination
- 2021-04-22 AU AU2021261803A patent/AU2021261803A1/en active Pending
- 2021-04-22 IL IL297432A patent/IL297432A/en unknown
- 2021-04-22 MX MX2022013311A patent/MX2022013311A/es unknown
- 2021-04-22 CN CN202110440285.0A patent/CN113527501A/zh active Pending
- 2021-04-22 EP EP21792313.5A patent/EP4141033A4/en active Pending
- 2021-04-22 BR BR112022021426A patent/BR112022021426A2/pt unknown
- 2021-04-22 JP JP2022564073A patent/JP2023522730A/ja active Pending
- 2021-04-22 WO PCT/CN2021/089059 patent/WO2021213475A1/zh active Application Filing
- 2021-04-22 US US17/996,878 patent/US20230151111A1/en active Pending
- 2021-04-22 CA CA3176321A patent/CA3176321A1/en active Pending
-
2022
- 2022-10-18 ZA ZA2022/11405A patent/ZA202211405B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11845795B2 (en) | NKp46 binding proteins | |
| RU2767357C2 (ru) | Биспецифические антитела-ингибиторы контрольных точек | |
| CA2987118C (en) | A pdl-1 antibody, pharmaceutical composition thereof and use thereof | |
| US11001629B2 (en) | Variable regions for NKp46 binding proteins | |
| US20220226469A1 (en) | Therapeutic sirp-alpha antibodies | |
| CA2903056A1 (en) | Tetravalent bispecific antibodies | |
| WO2017125897A1 (en) | Multispecific molecules targeting cll-1 | |
| US20230052369A1 (en) | Antibody constructs binding 4-1bb and tumor-associated antigens and uses thereof | |
| US20230279108A1 (en) | Therapeutic sirp-alpha antibodies | |
| CN115175702A (zh) | 用于体内生物靶向的材料和方法 | |
| US20180371089A1 (en) | Asymmetric heterodimeric fc-scfv fusion anti-globo h and anti-cd3 bispecific antibody and uses thereof in caner therapy | |
| JPWO2021213475A5 (ko) | ||
| AU2022332499A1 (en) | Fap/cd40 binding molecule and medicinal use thereof | |
| US20230265202A1 (en) | Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof | |
| CA3227854A1 (en) | Novel anti-sirpa antibodies | |
| AU2021224787A1 (en) | CD137 binding molecules and uses thereof | |
| RU2024107310A (ru) | Радиоконъюгаты к psma и способы их применения | |
| NZ735607B2 (en) | Cd20 binding molecules and uses thereof |